NAT10 and pancreatic ductal adenocarcinoma: AKT activation and cell proliferation characteristics were positively correlated (Figures 8D, E), suggesting that the abnormal expression of NAT10 may promote the malignant proliferation of pancreatic ductal adenocarcinoma by activating the PI3K-AKT pathway.